.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Deloitte
Merck
Baxter
Covington
Cantor Fitzgerald
Colorcon
Moodys
Cerilliant

Generated: September 21, 2017

DrugPatentWatch Database Preview

DIASTAT Drug Profile

« Back to Dashboard

Which patents cover Diastat, and when can generic versions of Diastat launch?

Diastat is a drug marketed by Valeant Pharms North and is included in one NDA.

The generic ingredient in DIASTAT is diazepam. There are eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.

Summary for Tradename: DIASTAT

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list47
Clinical Trials: see list4
Patent Applications: see list7,874
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIASTAT at DailyMed

Pharmacology for Tradename: DIASTAT

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-001Jul 29, 1997RXYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT ACUDIAL
diazepam
GEL;RECTAL020648-006Sep 15, 2005RXYesYes► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-004Jul 29, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-002Jul 29, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-003Jul 29, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT ACUDIAL
diazepam
GEL;RECTAL020648-007Sep 15, 2005RXYesNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-005Jul 29, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DIASTAT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-001Jul 29, 1997► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-005Jul 29, 1997► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-004Jul 29, 1997► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-003Jul 29, 1997► Subscribe► Subscribe
Valeant Pharms North
DIASTAT
diazepam
GEL;RECTAL020648-002Jul 29, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: DIASTAT

Drugname Dosage Strength RLD Submissiondate
diazepamRectal Gel5 mg/mL, 2mL pre-filled syringeDiastat Acudial12/23/2008
diazepamRectal Gel5 mg/mL, 4mL pre-filled syringeDiastat Acudial12/8/2008
diazepamRectal Gel2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL, 15 mg/3 mL and 20 mg/4 mLDiastat3/23/2004
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Colorcon
Cantor Fitzgerald
Federal Trade Commission
Harvard Business School
Dow
Cerilliant
Express Scripts
Moodys
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot